Comparison of glycemic control in diabetic patients with and without metabolic syndrome
DOI:
https://doi.org/10.31053/1853.0605.v70.n4.7462Keywords:
metabolic syndrome, glycemic control, diabetesAbstract
Objective: To compare the glycemic level patients with type 2 diabetes (T2DM) with and without Metabolic syndrome (MS).
Methodology: cross sectional study. Included patients randomly DM2 corroborated in your clinical record. The SM was identified in patients with at least 3 of 5 criteria of ATP III (Adult Treatment Panel III). A questionnaire was structured. Hemoglobin was determined (HbA1c), HDL-cholesterol, triglycerides, hypertension (HBP), body mass index (BMI), waist circumference (WC) and hip (NCC).
Results: 283 patients were included. Mean age was 59.8 ± 10.6. The predominant sex was female (73.6%). SM Criteria were : low HDL: 62.9%; hypertriglyceridemia: 56.3%; obesity abdominal (OA) 90.1%, hypertension (HBP): 62.5%. The prevalence of MS
was 86.6% (95% CI 83% to 89%). There was significant difference in mean HbA1c level in patients with and without MS, HAS, OR, and low HDL. In contrast, subjects with hypertriglyceridemia had an HbA1c level significantly higher than those without hypertriglyceridemia (8.9% 2.3 vs 8.5% 2.1, respectively, P = 0.01). HbA1c is positively correlated with triglycerides (r = 0.24, p = 0.001), and negatively with weight (r = -0.19, p = 0.001), BMI (r = -0172, p = 0.004), CCI (r = -0.12, P = 0.004) and CCA (r = -0.14, p = 0.02). In adjusted multivariate analysis, only the duration of diabetes was associated with glycemic level (OR = 1.014, 95% in 1.010 to 1.016).
Conclusions: We not found differences significant glycemic level in patients with and without MS.
Downloads
References
Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365(9468):1415-28. Epub 2005/04/20.
Zimmet P, Alberti K, Serrano M. Una nueva definición mundial del síndrome metabólico propuesta por la Federación Internacional de Diabetes: fundamento y resultados. Rev Esp Cardiol. 2005;58(12):1371-6.
Rodríguez Porto AL, Sánchez León M, Martínez Valdés LL. Síndrome metabólico. Revista Cubana de Endocrinología. 2002;13(3):0-.
Lacraustra G, Bergua M, Pascual C, Casasnovas L. Síndrome metabólico: Concepto y fisiopatología. Rev Esp Cardiol Supl. 2005;5:3D-10D.
2006 INdSPENdSyN. Resultados por entidad federativa, Veracruz. Cuernavaca, México: Instituto Nacional de Salud Pública-Secretaría de Salud. 2007.
Pública INdS. boletín de práctica médica efectiva. secretaria de salud. 2006.
González Sarmiento E, Pascual Calleja I, Laclaustra Gimeno M, Casasnovas Lenguas JA. Síndrome metabólico y diabetes mellitus. Revista Española de Cardiología Suplemen- tos. 2005;5(4):30D-7D.
Chen J, Wildman RP, Hamm LL, Muntner P, Reynolds K, Whelton PK, et al. Association Between Inflammation and Insulin Resistance in US Nondiabetic Adults Results from the Third National Health and Nutrition Examination Survey. Diabetes Care. 2004;27(12):2960-
Joffe H, Cohen LS, Suppes T, Hwang CH, Molay F, Adams JM, et al. Longitudinal followup of reproductive and metabolic features of valproate-associated polycystic ovarian syndrome features: A preliminary report. Biological psychiatry. 2006;60(12):1378-81. Epub 2006/09/05.
Goodman D, Fraga MA, Brodine S, Ibarra MD, Garfein RS. Prevalence of diabetes and metabolic syndrome in a migrant Mixtec population, baja california, Mexico. Journal of immigrant and minority health / Center for Minority Public Health. 2013;15(1):93-100. Epub 2012/09/11.
Lin JD, Lin LP, Liou SW, Chen YC, Hsu SW, Liu CT. Gender differences in the prevalence of metabolic syndrome and its components among adults with disabilities based on a community health check up data. Research in developmental disabilities. 2013;34(1):516-20. Epub 2012/10/23.
Novak M, Bjorck L, Welin L, Welin C, Manhem K, Rosengren A. Gender differences in the prevalence of metabolic syndrome in 50-yearold Swedish men and women with hypertension born in 1953. Journal of human hypertension. 2013;27(1):56-61. Epub 2011/12/02.
Ojji DB, Ajayi SO, Mamven MH, Alabi P. Prevalence of metabolic syndrome among hypertensive patients in Abuja, Nigeria. Ethnicity & disease. 2012;22(1):1-4. Epub 2012/07/11.
Saukkonen T, Jokelainen J, Timonen M, Cederberg H, Laakso M, Harkonen P, et al. Prevalence of metabolic syndrome components among the elderly using three different definitions: a cohort study in Finland. Scandinavian journal of primary health care. 2012;30(1):29- 34. Epub 2012/02/14.
Milton JS, Tsokos J. Estadística para biología y ciencias de la salud1987.
NOM-028-SSA2-1999 NOM. Para la prevención, tratamiento y control de las adicciones. 1999;2(6).
Gimeno ML, Martínez CB, Calleja IP, Lenguas JAC. Síndrome metabólico. Concepto y fisiopatología.
Armua MCR, Giuggia NMB, de Lapertosa SG. Frecuencia del sindrome meta - bolico en pa cientes con diabetes mellitus tipo 2 en un servicio de diabetes de corrientes.
López-Maldonado FJ, Reza-Albarrán AA, Suárez ÓJ, Villa AR, Ríos-Vaca A, Gómez-Péreza FJ, et al. Grado de control de factores de riesgo cardiovascular en una población de pacientes con diabetes mellitus tipo 1 y 2 de difícil manejo. Gac Med Mex. 2009;145(1).
Lombo B, Satizábal C, Villalobos C, Tique C, Kattah W. Prevalencia del síndrome metabólico en pacientes diabéticos. Acta Med Colomb. 2007;32(1):9-15.
Gimeno Orna J, Boned Juliani B, Lou Arnal L, Castro Alonso F, editors. Factores relacionados con el control glucémico de pacientes con diabetes tipo 2. Anales de Medicina Interna; 2003: SciELO Espana.
Lee IT, Chiu YF, Hwu CM, He CT, Chiang FT, Lin YC, et al. Central obesity is important but not essential component of the metabolic syndrome for predicting diabetes mellitus in a hypertensive family-based cohort. Results from the Stanford Asia-pacific program for hypertension and insulin resistance (SAPPHIRe)
Taiwan follow-up study. Cardiovascular diabetology. 2012;11:43. Epub 2012/04/28.
Zhang L, Zhang WH, Wang PY. Prevalence of overweight/obesity and its associations with hypertension, diabetes, dyslipidemia, and metabolic syndrome: a survey in the suburban area of Beijing, 2007. Obesity facts.
;4(4):284-9. Epub 2011/09/17.
Gaillard T, Schuster D, Osei K. Differential impact of serum glucose, triglycerides, and high-density lipoprotein cholesterol on cardiovascular risk factor burden in nondiabetic, obese African American women: mplications for the prevalence of metabolic syndrome. Metabolism: clinical and experimental. 2010;59(8):1115-23. Epub 2010/01/07. 25. Frazier-Wood AC, Glasser S, Garvey WT, Kabagambe EK, Borecki IB, Tiwari HK, et al. A clustering analysis of lipoprotein diameters in the metabolic syndrome. Lipids in health and disease. 2011;10:237. Epub 2011/12/21.
Worawongprapa O. Glycemic control in diabetes with metabolic syndrome in community hospital. Journal of the Medical Association of Thailand = Chotmaihet thangphaet. 2008;91(5):641-7. Epub 2008/08/05.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2013 Universidad Nacional de Córdoba
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The Faculty of Medical Sciences Journal (RFCM) subscribes to the Open Access policy and does not charge authors fees for publishing, nor does it charge readers fees for accessing published articles (APC).
